About
Portfolio
News
Contact
Contact us
Join Us
News
News
2023.03.25
Neurelis announces first healthy subjects dosed in investigational study of nrl-1049, a rho kinase ...
2023.03.25
Neurelis announces first healthy subjects dosed in investigational study of nrl-1049, a rho kinase ...
view more
2023.03.03
Neurelis Wins 2023 Pm360 Pharma Choice Multichannel Gold Award For 'Give Seizures The S...
2023.03.03
Neurelis Wins 2023 Pm360 Pharma Choice Multichannel Gold Award For 'Give Seizures The S...
view more
2023.01.30
Alpha Biopharma Submits New Drug Application for Zorifertinib, a Next-Generation EGFR-T...
2023.01.30
Alpha Biopharma Submits New Drug Application for Zorifertinib, a Next-Generation EGFR-T...
view more
2023.01.24
Wugen Presents Data Supporting Clinical Development of WU-NK-101 for Relapsed / Refracto...
2023.01.24
Wugen Presents Data Supporting Clinical Development of WU-NK-101 for Relapsed / Refracto...
view more
2023.01.10
Neurelis announces filing of its investigational new drug application for nrl-1049, a rho kinase (r...
2023.01.10
Neurelis announces filing of its investigational new drug application for nrl-1049, a rho kinase (r...
view more
2022.12.13
Wugen Presents Data Supporting Clinical Development of WU-NK-101 for Relapsed / Refracto...
2022.12.13
Wugen Presents Data Supporting Clinical Development of WU-NK-101 for Relapsed / Refracto...
view more
1
2
3
4
5
6
7
8
...
11
12
2023.03.25
